Post by SOPHiA GENETICS

🚀 Introducing SOPHiA DDM™ Digital Twins from #ESMO Today, SOPHiA GENETICS launches AI-powered Digital Twins: a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment decisions. “By simulating disease trajectories and therapeutic responses within a virtual environment, Digital Twins offer a framework for in silico experimentation, supporting anticipatory and individualized clinical decision-making," said Dr. Pierre Heudel, Medical Oncologist, Centre Léon Bérard. SOPHiA DDM™ Digital Twins enables researchers and clinicians to combine each patient’s clinical, biological, imaging, and genomic data, exploring possible treatment strategies virtually before they’re applied in real life, bringing predictive insight closer to the bedside. Dr. Mariano Provencio Pulla, Head of the Medical Oncology Department, Puerta de Hierro University Hospital, added, “The Digital Twins concept developed by SOPHiA GENETICS is really a breakthrough in oncology. I truly believe that it is the future of data-driven medicine.” “With SOPHiA DDM™ Digital Twins, we can create advanced AI models based on our broad patient network, accelerating research, sharpening clinical decisions, and turning today’s insights into tomorrow’s breakthroughs. This reflects our ambition to make data-driven medicine the global standard of care,” said Jurgi Camblong, Ph.D., Co-Founder & CEO, SOPHiA GENETICS. 🔬 The first release focuses on lung cancer, with additional cancer types coming soon. To learn more about Digital Twins, connect with the team at ESMO in Berlin, Germany from October 17 – 21, or visit our website: https://loom.ly/rfl5nl4 ESMO - European Society for Medical Oncology #ESMO2025 #AIinHealthcare #Oncology #DigitalTwins #DataDrivenMedicine